Gilead Sciences Inc. Common Stock (GILD)

About GILD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary bi…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

17,000

Website

www.gilead.com

Fundamentals

1-day range

$135.91$138.43

Market cap

$162.47B

P/E (trailing)

—

P/E (forward)

14.01

EPS (trailing)

$-2.66

Dividend yield

2.37%

Beta

0.34

Avg. volume

7.68M

Ex-dividend date

September 15, 2026

Dividend pay date

September 29, 2026

Forecasts

27 analyst ratings

Gilead Sciences Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• GILD

  Gilead Sciences Inc. Common Stock

  $145.68

  ▼ 2.14%
  Market cap $162.47BP/E —
  $108.46$157.29
• ARGX

  argenx SE American Depositary Shares

  $1,025

  ▼ 3.22%
  Market cap $54.32BP/E 22.19
  $568.4$913
• RVMD

  Revolution Medicines Inc. Common Stock

  $207.89

  ▼ 6.00%
  Market cap $42.05BP/E —
  $35.64$224.31
• BNTX

  BioNTech SE American Depositary Share

  $102.04

  ▼ 8.40%
  Market cap $22.91BP/E —
  $79.52$124
• MRNA

  Moderna Inc. Common Stock

  $137.93

  ▼ 3.39%
  Market cap $21.50BP/E —
  $22.28$176.66
• NBIX

  Neurocrine Biosciences Inc. Common Stock

  $153.98

  ▼ 1.24%
  Market cap $16.25BP/E 22.33
  $122.14$186.12
• HALO

  Halozyme Therapeutics Inc. Common Stock

  $105.33

  ▼ 1.49%
  Market cap $10.17BP/E 27.63
  $61.23$109.66

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Making Drugs With AI: Biopharma Giants Gear Up For New Arena
  Yahoo · 8/21/2026
• Does Gilead (GILD) Pairing With Nucleai Reveal a Deeper Shift in Its Oncology Strategy?
  Yahoo · 8/20/2026
• Worried About a Market Crash? These 3 Stocks Beat the S&P 500 in 2008 and 2022
  Yahoo · 8/19/2026
• Biotech Stocks Are Booming. What This Top Fund Is Buying Now.
  Yahoo · 8/19/2026
• HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
  Yahoo · 8/19/2026
• Is Gilead's Expanding HIV Portfolio a Growth Catalyst?
  Yahoo · 8/18/2026
• Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
  Yahoo · 8/18/2026
• Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
  Yahoo · 8/18/2026

• Wettan Keeley M. Cain · August 10, 2026 · Option Exercise

  6.0K
• Wettan Keeley M. Cain · August 10, 2026 · Tax Withholding

  2.9K @ $133.06
• Daniel Patrick O'Day · August 3, 2026 · Sale

  600 @ $131.34
• Daniel Patrick O'Day · August 3, 2026 · Sale

  7.7K @ $130.8
• Daniel Patrick O'Day · August 3, 2026 · Sale

  6.7K @ $129.66
• Johanna Mercier · July 15, 2026 · Sale

  3.0K @ $129.92
• Andrew D. Dickinson · July 15, 2026 · Sale

  3.0K @ $129.93
• Daniel Patrick O'Day · July 1, 2026 · Sale

  3.1K @ $127.08
• Daniel Patrick O'Day · July 1, 2026 · Sale

  11.9K @ $126.09
• Johanna Mercier · June 15, 2026 · Sale

  450 @ $125.4
• Johanna Mercier · June 15, 2026 · Sale

  1.1K @ $124
• Johanna Mercier · June 15, 2026 · Sale

  1.5K @ $123.42
• Andrew D. Dickinson · June 15, 2026 · Sale

  3.0K @ $125.4
• Wettan Keeley M. Cain · June 10, 2026 · Option Exercise

  589
• Wettan Keeley M. Cain · June 10, 2026 · Tax Withholding

  283 @ $121.48

Institutional Ownership

March 31, 2026

Total shares held

989.59M

Total value held

$130.71B

Institutional holders

2290